CorMedix (CRMD) Exchange Rate Effect (2015 - 2025)
CorMedix (CRMD) posted Exchange Rate Effect of $276.0 for Q3 2025, down 66.67% sequentially from $828.0 in Q2 2025, and down 33.49% YoY from $415.0 in Q3 2024.
CorMedix (CRMD) Exchange Rate Effect (2015 - 2025) Analysis & Trends
CorMedix has reported Exchange Rate Effect for 11 years, with the latest figure at $276.0 in Q3 2025.
- Quarterly Exchange Rate Effect fell 33.49% year-over-year to $276.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$189.0 (down 109.72% YoY) and the FY2024 annual result came in at -$2000.0, down 171.23% from the prior year.
- Exchange Rate Effect fell to $276.0 in Q3 2025 per CRMD's latest filing, from $828.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $15787.0 in Q4 2022 and troughed at -$10909.0 in Q3 2022.
- A 5-year average of -$1023.9 and a median of -$88.0 in 2024 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 438.75% in 2022, then soared 1040.91% in 2025.
- Over 5 years, Exchange Rate Effect stood at -$3120.0 in 2021, then surged by 605.99% to $15787.0 in 2022, then plunged by 84.65% to $2423.0 in 2023, then sank by 162.81% to -$1522.0 in 2024, then soared by 118.13% to $276.0 in 2025.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $276.0, $828.0, and $229.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 276.00 |
| Sep 30, 2025 | 276.00 |
| Jun 30, 2025 | 828.00 |
| Jun 30, 2025 | 828.00 |
| Mar 31, 2025 | 229.00 |
| Mar 31, 2025 | 229.00 |
| Dec 31, 2024 | -1,522.00 |
| Dec 31, 2024 | -1,522.00 |
| Sep 30, 2024 | 415.00 |
| Sep 30, 2024 | 415.00 |
| Jun 30, 2024 | -88.00 |
| Jun 30, 2024 | -88.00 |
| Mar 31, 2024 | -805.00 |
| Mar 31, 2024 | -805.00 |
| Dec 31, 2023 | 2,423.00 |
| Dec 31, 2023 | 2,423.00 |
| Sep 30, 2023 | -2,146.00 |
| Sep 30, 2023 | -2,146.00 |
| Jun 30, 2023 | 247.00 |
| Jun 30, 2023 | 247.00 |